BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 29534960)

  • 21. Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences.
    Rolim AE; Henrique-Araújo R; Ferraz EG; de Araújo Alves Dultra FK; Fernandez LG
    Gene; 2015 Jan; 554(2):131-9. PubMed ID: 25445283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced tandem mass spectrometry in metabolomics and lipidomics-methods and applications.
    Heiles S
    Anal Bioanal Chem; 2021 Oct; 413(24):5927-5948. PubMed ID: 34142202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable isotope analysis of dynamic lipidomics.
    Brandsma J; Bailey AP; Koster G; Gould AP; Postle AD
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):792-796. PubMed ID: 28302590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry.
    Xuan Q; Hu C; Yu D; Wang L; Zhou Y; Zhao X; Li Q; Hou X; Xu G
    Anal Chem; 2018 Jun; 90(12):7608-7616. PubMed ID: 29807422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics analysis of lipid metabolizing enzyme activity.
    Ware TB; Shin M; Hsu KL
    Methods Enzymol; 2019; 626():407-428. PubMed ID: 31606084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Top-down and bottom-up lipidomic analysis of rabbit lipoproteins under different metabolic conditions using flow field-flow fractionation, nanoflow liquid chromatography and mass spectrometry.
    Byeon SK; Kim JY; Lee JY; Chung BC; Seo HS; Moon MH
    J Chromatogr A; 2015 Jul; 1405():140-8. PubMed ID: 26087967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
    Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
    Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry.
    Wang S; Zhou L; Wang Z; Shi X; Xu G
    Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of ion-mobility mass spectrometry for lipid analysis.
    Paglia G; Kliman M; Claude E; Geromanos S; Astarita G
    Anal Bioanal Chem; 2015 Jul; 407(17):4995-5007. PubMed ID: 25893801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting human urinary metabolome by LC-MS/MS: a review.
    Rodríguez-Morató J; Pozo ÓJ; Marcos J
    Bioanalysis; 2018 Apr; 10(7):489-516. PubMed ID: 29561651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Untargeted and Targeted Circadian Metabolomics Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Flow Injection-Electrospray Ionization-Tandem Mass Spectrometry (FIA-ESI-MS/MS).
    Artati A; Prehn C; Lutter D; Dyar KA
    Methods Mol Biol; 2022; 2482():311-327. PubMed ID: 35610436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Moderate and High-Resolution Mass Spectrometry for Class-Specific Lipid Identification and Quantification.
    Del Carmen Piqueras M
    Methods Mol Biol; 2017; 1609():83-90. PubMed ID: 28660576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted LC-MS/MS-based metabolomics and lipidomics on limited hematopoietic stem cell numbers.
    Schönberger K; Mitterer M; Buescher JM; Cabezas-Wallscheid N
    STAR Protoc; 2022 Jun; 3(2):101408. PubMed ID: 35620073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in using mass spectrometry for mitochondrial metabolomics and lipidomics - A review.
    Liu X; Xu G
    Anal Chim Acta; 2018 Dec; 1037():3-12. PubMed ID: 30292306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shotgun lipidomics of neutral lipids as an enabling technology for elucidation of lipid-related diseases.
    Gross RW; Han X
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E297-303. PubMed ID: 19126783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unbiased Lipidomics and Metabolomics of Human Brain Samples.
    Astarita G; Stocchero M; Paglia G
    Methods Mol Biol; 2018; 1750():255-269. PubMed ID: 29512078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-step lipid extraction for plasma lipidomics analysis by liquid chromatography mass spectrometry.
    Satomi Y; Hirayama M; Kobayashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():93-100. PubMed ID: 28850891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis.
    Dalli J; Colas RA; Walker ME; Serhan CN
    Methods Mol Biol; 2018; 1730():59-72. PubMed ID: 29363065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC-MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model.
    Liu J; Zhao M; Zhu Y; Wang X; Zheng L; Yin Y
    J Proteome Res; 2019 Jan; 18(1):48-56. PubMed ID: 30543107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.